113 related articles for article (PubMed ID: 2499663)
1. Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.
Ajani JA; Rios AA; Ende K; Abbruzzese JL; Edwards C; Faintuch JS; Saks S; Gutterman JU; Levin B
J Biol Response Mod; 1989 Apr; 8(2):140-6. PubMed ID: 2499663
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
3. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
4. Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.
Wadler S; Haynes H; Rozenblit A; Hu X; Kaleya R; Wiernik PH
Cancer J Sci Am; 1998; 4(5):331-7. PubMed ID: 9815298
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
Lillis PK; Brown TD; Beougher K; Koeller J; Marcus SG; Von Hoff DD
Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
[TBL] [Abstract][Full Text] [Related]
8. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
11. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
[TBL] [Abstract][Full Text] [Related]
12. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
Petrelli NJ; Madajewicz S; Herrera L; Rustum YM; Trave F; Creaven P; Mittelman A
NCI Monogr; 1987; (5):189-92. PubMed ID: 3501541
[TBL] [Abstract][Full Text] [Related]
13. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
14. [Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
Hirao M; Fujitani K; Tsujinaka T
Gan To Kagaku Ryoho; 2005 Jan; 32(1):53-6. PubMed ID: 15675582
[TBL] [Abstract][Full Text] [Related]
15. The activity of paclitaxel in gastrointestinal tumors.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.
Abbruzzese JL; Levin B; Ajani JA; Faintuch JS; Pazdur R; Saks S; Edwards C; Gutterman JU
J Biol Response Mod; 1990 Oct; 9(5):522-7. PubMed ID: 2123922
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.
Morikawa K; Fan D; Denkins YM; Levin B; Gutterman JU; Walker SM; Fidler IJ
Cancer Res; 1989 Feb; 49(4):799-805. PubMed ID: 2492206
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of melphalan in colorectal carcinoma.
DiBenedetto J; Moayeri H; Evans JT; Mittelman A
Cancer Treat Rep; 1978 Sep; 62(9):1401-2. PubMed ID: 688286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
